Monday, August 24, 2026

Is North Korea Ready for a 12-Year-Old Leader? Inside Kim Jong Un’s Bold Move

Former Minister Jeong Se-hyun interprets Kim Jong-un's designation of his 12-year-old daughter as successor as a response to his own brief training.

A.X K1: How SK Telecom’s Groundbreaking AI Model is Redefining the Future of Technology in Asia

SK Telecom's A.X K1 AI model is gaining global attention, outperforming rivals and showcasing Korea's rapid AI advancements.

K-Beauty to drive global growth through convergence with biotech and fashion, KHIDI official says [Moon Dae-hyun’s MediView]

K-beauty aims for growth by integrating with biotech, medical devices, and fashion, enhancing global competitiveness and sustainability.

Tag: Alzheimer's treatment

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

Can Donanemab Expand Alzheimer’s Treatment to Lewy Body Dementia? Key Insights from Korean Lilly’s Latest Clinical Trials

Lilly has launched a global trial for Kisunla, targeting Lewy body dementia, aiming to expand its Alzheimer's treatment to this underserved area.

Samjin Pharm Just Made a Move That Could Shake Up the Alzheimer’s Treatment Market

Samjin Pharmaceutical launches Newtoin Duo Tab, a dual-action Alzheimer’s treatment, enhancing medication adherence for patients.

Alzheimer’s Breakthrough: Monthly Injections of IVL3003 vs. GB-5001A—Which is More Effective?

New long-acting injectable formulations of donepezil for Alzheimer's aim to improve adherence and efficacy, easing caregiver burdens.

South Korean Biotech Seeks Breakthrough in $Trillion-Scale Alzheimer’s Market

AriBio's AR1001 is a promising oral Alzheimer's drug aiming for global blockbuster status by 2027, focusing on convenience and safety.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.